Liquidia Technologies (NASDAQ:LQDA) Insider Jason Adair Sells 26,057 Shares

Liquidia Technologies, Inc. (NASDAQ:LQDA) insider Jason Adair sold 26,057 shares of the business’s stock in a transaction on Thursday, August 28th. The stock was sold at an average price of $27.86, for a total value of $725,948.02. Following the completion of the transaction, the insider directly owned 171,029 shares of the company’s stock, valued at approximately $4,764,867.94. This trade represents a 13.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Jason Adair also recently made the following trade(s):

• On Tuesday, September 2nd, Jason Adair sold 451 shares of Liquidia Technologies stock. The stock was sold at an average price of $29.05, for a total value of $13,101.55.
• On Tuesday, September 2nd, Jason Adair sold 451 shares of Liquidia Technologies stock. The stock was sold at an average price of $29.05, for a total value of $13,101.55.
• On Monday, July 28th, Jason Adair sold 454 shares of Liquidia Technologies stock. The stock was sold at an average price of $19.54, for a total value of $8,871.16.
• On Monday, July 14th, Jason Adair sold 2,576 shares of Liquidia Technologies stock. The stock was sold at an average price of $14.28, for a total value of $36,785.28.

Liquidia Technologies Price Performance

Shares of NASDAQ:LQDA opened at $29.22 on Thursday. The company has a market cap of $2.52 billion, a P/E ratio of -17.19 and a beta of 0.22. The company has a quick ratio of 2.41, a current ratio of 2.49 and a debt-to-equity ratio of 9.84. Liquidia Technologies, Inc. has a 52 week low of $8.75 and a 52 week high of $29.94. The business has a fifty day simple moving average of $19.79 and a 200-day simple moving average of $16.61.

Liquidia Technologies (NASDAQ:LQDA) last announced its quarterly earnings data on Tuesday, August 12th. The company reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.43) by ($0.06). The business had revenue of $8.84 million during the quarter, compared to analysts’ expectations of $3.90 million. Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The firm’s quarterly revenue was up 141.5% compared to the same quarter last year. Equities research analysts forecast that Liquidia Technologies, Inc. will post -1.51 EPS for the current year.

Institutional Investors Weigh In On Liquidia Technologies

Several institutional investors and hedge funds have recently modified their holdings of LQDA. NewEdge Advisors LLC purchased a new stake in shares of Liquidia Technologies in the second quarter worth about $25,000. Hurley Capital LLC purchased a new stake in shares of Liquidia Technologies in the first quarter worth about $32,000. GAMMA Investing LLC boosted its position in shares of Liquidia Technologies by 65.6% in the first quarter. GAMMA Investing LLC now owns 2,961 shares of the company’s stock worth $44,000 after buying an additional 1,173 shares during the period. Steward Partners Investment Advisory LLC boosted its position in shares of Liquidia Technologies by 24.0% in the second quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company’s stock worth $77,000 after buying an additional 1,200 shares during the period. Finally, Quarry LP purchased a new stake in shares of Liquidia Technologies in the first quarter worth about $79,000. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on LQDA. Oppenheimer set a $13.00 price objective on Liquidia Technologies and gave the company an “underperform” rating in a research report on Monday, May 19th. Scotiabank lifted their price objective on Liquidia Technologies from $36.00 to $37.00 and gave the company a “sector outperform” rating in a research report on Wednesday, May 28th. Bank of America lowered their price objective on Liquidia Technologies from $25.00 to $23.00 and set a “buy” rating for the company in a research report on Wednesday, June 11th. HC Wainwright lifted their price objective on Liquidia Technologies from $29.00 to $35.00 and gave the company a “buy” rating in a research report on Wednesday, May 28th. Finally, Jefferies Financial Group assumed coverage on Liquidia Technologies in a research report on Friday, August 15th. They set a “buy” rating and a $43.00 price target for the company. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $32.11.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).